EARNINGS PER SHARE

9 Months Ended

Sep. 30, 2024

The numerator for both basic and diluted earnings per share (“EPS”) is Net income attributable to GE HealthCare common stockholders. The denominator of basic EPS is the weighted-average number of shares outstanding during the period. The dilutive effect of outstanding stock options, restricted stock units, and performance share units is reflected in the denominator for diluted EPS using the treasury stock method.


Earnings Per Share	For the three months ended September 30				For the nine months ended September 30
(In millions, except per share amounts)	2024		2023		2024		2023
Numerator:
Net income from continuing operations	$	490	$	386	$	1,312	$	1,202
Net (income) loss attributable to noncontrolling interests	(19)		(7)		(40)		(33)
Net income from continuing operations attributable to GE HealthCare	470		379		1,272		1,169
Deemed preferred stock dividend of redeemable noncontrolling interest	—		—		—		(183)
Net income from continuing operations attributable to GE HealthCare common stockholders	470		379		1,272		986
Income (loss) from discontinued operations, net of taxes	—		(4)		—		(4)
Net income attributable to GE HealthCare common stockholders	$	470	$	375	$	1,272	$	982
Denominator:
Basic weighted-average shares outstanding	457		455		456		455
Dilutive effect of common stock equivalents	2		3		2		3
Diluted weighted-average shares outstanding	459		458		459		458
Basic Earnings Per Share:
Continuing operations	$	1.03	$	0.83	$	2.79	$	2.17
Discontinued operations	—		(0.01)		—		(0.01)
Attributable to GE HealthCare common stockholders	1.03		0.82		2.79		2.16
Diluted Earnings Per Share:
Continuing operations	$	1.02	$	0.83	$	2.77	$	2.16
Discontinued operations	—		(0.01)		—		(0.01)
Attributable to GE HealthCare common stockholders	1.02		0.82		2.77		2.15
Antidilutive securities(1)	2		4		4		4

(1) Diluted earnings per share excludes certain shares issuable under share-based compensation plans because the effect would have been antidilutive.